BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1112 related articles for article (PubMed ID: 18173519)

  • 41. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index.
    Pucci N; Novembre E; Cammarata MG; Bernardini R; Monaco MG; Calogero C; Vierucci A
    Allergy; 2005 Jan; 60(1):113-6. PubMed ID: 15575941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features of atopic dermatitis in a hospital-based setting in China.
    Shi M; Zhang H; Chen X; Guo Y; Tao J; Qi H; Gan J; Jiang A; Yu H; Liang J; Chen J; Yang L; Zhuang Y; Yan M; Gu Y; Yu X; Feng X; Yao Z
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1206-12. PubMed ID: 21214635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
    Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
    J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
    Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
    Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis.
    Yen CH; Dai YS; Yang YH; Wang LC; Lee JH; Chiang BL
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):66-73. PubMed ID: 18254485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
    Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
    J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
    Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
    Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool.
    Carel K; Bratton DL; Miyazawa N; Gyorkos E; Kelsay K; Bender B; Strand M; Atkins D; Gelfand EW; Klinnert MD
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):500-7. PubMed ID: 19055204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of polyunsaturated fatty acids in children with atopic dermatitis and in atopic and nonatopic controls.
    Focke M; Sesztak-Greinecker G; Brannath W; Götz M; Jarisch R; Hemmer W
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):485-91. PubMed ID: 16091876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
    Wang F; He D; Tang X; Zhang X
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.
    Park JH; Choi YL; Namkung JH; Kim WS; Lee JH; Park HJ; Lee ES; Yang JM
    Br J Dermatol; 2006 Oct; 155(4):778-83. PubMed ID: 16965428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural history of atopic dermatitis and its relationship to serum total immunoglobulin E in a population-based birth cohort study.
    Perkin MR; Strachan DP; Williams HC; Kennedy CT; Golding J;
    Pediatr Allergy Immunol; 2004 Jun; 15(3):221-9. PubMed ID: 15209954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S; Nakamura K; Oyama N; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum levels of anti-Staphylococcus aureus-specific IgE in patients with atopic dermatitis.
    Yamada H; Yudate T; Orita T; Tezuka T
    J Clin Lab Immunol; 1996; 48(4):167-75. PubMed ID: 9819668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The predictive value of IgE as biomarker in asthma.
    Ahmad Al Obaidi AH; Mohamed Al Samarai AG; Yahya Al Samarai AK; Al Janabi JM
    J Asthma; 2008 Oct; 45(8):654-63. PubMed ID: 18951256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
    Oldhoff JM; Darsow U; Werfel T; Katzer K; Wulf A; Laifaoui J; Hijnen DJ; Plötz S; Knol EF; Kapp A; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
    Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased bronchial NO output in severe atopic eczema in children and adolescents.
    Linkosalo L; Lehtimäki L; Laitinen J; Kaila M; Holm K; Moilanen E
    Pediatr Allergy Immunol; 2008 Aug; 19(5):426-32. PubMed ID: 18167156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.